久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/23 | 3,425 | 3,480 | 3,420 | 3,455 | +40 | +1.2% | 170,800 |
2022/06/22 | 3,395 | 3,425 | 3,360 | 3,415 | +45 | +1.3% | 172,700 |
2022/06/21 | 3,390 | 3,390 | 3,335 | 3,370 | +20 | +0.6% | 142,300 |
2022/06/20 | 3,360 | 3,385 | 3,335 | 3,350 | ±0 | ±0% | 110,400 |
2022/06/17 | 3,295 | 3,365 | 3,285 | 3,350 | +40 | +1.2% | 353,900 |
2022/06/16 | 3,320 | 3,360 | 3,300 | 3,310 | -5 | -0.2% | 182,300 |
2022/06/15 | 3,305 | 3,335 | 3,290 | 3,315 | ±0 | ±0% | 154,900 |
2022/06/14 | 3,315 | 3,345 | 3,295 | 3,315 | -35 | -1% | 183,100 |
2022/06/13 | 3,320 | 3,365 | 3,320 | 3,350 | +10 | +0.3% | 141,600 |
2022/06/10 | 3,365 | 3,375 | 3,340 | 3,340 | -60 | -1.8% | 192,200 |
2022/06/09 | 3,395 | 3,430 | 3,390 | 3,400 | -30 | -0.9% | 150,200 |
2022/06/08 | 3,380 | 3,435 | 3,375 | 3,430 | +80 | +2.4% | 165,800 |
2022/06/07 | 3,355 | 3,380 | 3,345 | 3,350 | -5 | -0.1% | 126,200 |
2022/06/06 | 3,350 | 3,370 | 3,345 | 3,355 | -15 | -0.4% | 124,700 |
2022/06/03 | 3,420 | 3,425 | 3,365 | 3,370 | -15 | -0.4% | 181,700 |
2022/06/02 | 3,435 | 3,435 | 3,380 | 3,385 | -75 | -2.2% | 145,100 |
2022/06/01 | 3,385 | 3,495 | 3,385 | 3,460 | +75 | +2.2% | 174,600 |
2022/05/31 | 3,445 | 3,480 | 3,385 | 3,385 | -60 | -1.7% | 365,500 |
2022/05/30 | 3,425 | 3,450 | 3,390 | 3,445 | +30 | +0.9% | 507,600 |
2022/05/27 | 3,410 | 3,440 | 3,385 | 3,415 | +25 | +0.7% | 148,000 |
2022/05/26 | 3,420 | 3,450 | 3,390 | 3,390 | -40 | -1.2% | 191,100 |
2022/05/25 | 3,460 | 3,480 | 3,430 | 3,430 | -30 | -0.9% | 117,300 |
2022/05/24 | 3,480 | 3,495 | 3,440 | 3,460 | -90 | -2.5% | 163,000 |
2022/05/23 | 3,480 | 3,550 | 3,445 | 3,550 | +130 | +3.8% | 191,300 |
2022/05/20 | 3,520 | 3,535 | 3,410 | 3,420 | -105 | -3% | 209,700 |
2022/05/19 | 3,450 | 3,545 | 3,445 | 3,525 | +5 | +0.1% | 198,500 |
2022/05/18 | 3,510 | 3,535 | 3,490 | 3,520 | +10 | +0.3% | 123,200 |
2022/05/17 | 3,465 | 3,550 | 3,465 | 3,510 | +50 | +1.4% | 122,500 |
2022/05/16 | 3,610 | 3,615 | 3,450 | 3,460 | -105 | -2.9% | 181,000 |
2022/05/13 | 3,555 | 3,595 | 3,515 | 3,565 | +15 | +0.4% | 193,900 |
2022/05/12 | 3,600 | 3,610 | 3,535 | 3,550 | -30 | -0.8% | 179,300 |
2022/05/11 | 3,555 | 3,595 | 3,520 | 3,580 | -20 | -0.6% | 184,100 |
2022/05/10 | 3,480 | 3,610 | 3,475 | 3,600 | +140 | +4% | 219,000 |
2022/05/09 | 3,525 | 3,540 | 3,460 | 3,460 | -115 | -3.2% | 183,100 |
2022/05/06 | 3,580 | 3,595 | 3,545 | 3,575 | -30 | -0.8% | 175,500 |
2022/05/02 | 3,560 | 3,630 | 3,530 | 3,605 | +30 | +0.8% | 179,700 |
2022/04/28 | 3,405 | 3,580 | 3,405 | 3,575 | +180 | +5.3% | 328,300 |
2022/04/27 | 3,380 | 3,410 | 3,350 | 3,395 | -40 | -1.2% | 506,800 |
2022/04/26 | 3,415 | 3,455 | 3,410 | 3,435 | +50 | +1.5% | 181,300 |
2022/04/25 | 3,330 | 3,410 | 3,325 | 3,385 | +10 | +0.3% | 161,200 |
2022/04/22 | 3,360 | 3,405 | 3,360 | 3,375 | -85 | -2.5% | 166,300 |
2022/04/21 | 3,420 | 3,485 | 3,420 | 3,460 | +40 | +1.2% | 138,500 |
2022/04/20 | 3,390 | 3,450 | 3,365 | 3,420 | +40 | +1.2% | 169,400 |
2022/04/19 | 3,345 | 3,390 | 3,335 | 3,380 | +65 | +2% | 159,400 |
2022/04/18 | 3,350 | 3,370 | 3,300 | 3,315 | -70 | -2.1% | 184,000 |
2022/04/15 | 3,420 | 3,435 | 3,375 | 3,385 | -105 | -3% | 197,100 |
2022/04/14 | 3,520 | 3,545 | 3,465 | 3,490 | -15 | -0.4% | 149,400 |
2022/04/13 | 3,390 | 3,525 | 3,390 | 3,505 | +115 | +3.4% | 295,500 |
2022/04/12 | 3,495 | 3,500 | 3,370 | 3,390 | -110 | -3.1% | 249,300 |
2022/04/11 | 3,610 | 3,635 | 3,500 | 3,500 | -110 | -3% | 243,500 |
701~
750
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム